These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 1983552)
1. [What is the value of tumor debulking and intraperitoneal cytostasis]. Laffer U; Knüsli C; Harder F Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():205-10. PubMed ID: 1983552 [TBL] [Abstract][Full Text] [Related]
2. Peritoneal surface malignancies and regional treatment: a review of the literature. Rubino MS; Abdel-Misih RZ; Bennett JJ; Petrelli NJ Surg Oncol; 2012 Jun; 21(2):87-94. PubMed ID: 21216590 [TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience). Markman M; Reichman B; Hakes T; Hoskins W; Rubin S; Jones W; Lewis JL Acta Med Austriaca; 1989; 16(3-4):65-7. PubMed ID: 2609915 [TBL] [Abstract][Full Text] [Related]
5. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy. Yu W Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532 [TBL] [Abstract][Full Text] [Related]
6. [Toxicity results of an adjuvant study with intraperitoneal chemotherapy in patients with stomach cancer. Current status and future prospects of intraperitoneal therapy]. Jakesz R; Böhmig HJ; Depisch D; Funovics J; Hamilton G; Hofbauer F; Schiessel R; Starlinger M Wien Klin Wochenschr; 1987 Jun; 99(12):415-20. PubMed ID: 3617769 [TBL] [Abstract][Full Text] [Related]
7. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150 [TBL] [Abstract][Full Text] [Related]
8. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis]. Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661 [TBL] [Abstract][Full Text] [Related]
9. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients. Rossi CR; Deraco M; De Simone M; Mocellin S; Pilati P; Foletto M; Cavaliere F; Kusamura S; Gronchi A; Lise M Cancer; 2004 May; 100(9):1943-50. PubMed ID: 15112276 [TBL] [Abstract][Full Text] [Related]
10. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. Feldman AL; Libutti SK; Pingpank JF; Bartlett DL; Beresnev TH; Mavroukakis SM; Steinberg SM; Liewehr DJ; Kleiner DE; Alexander HR J Clin Oncol; 2003 Dec; 21(24):4560-7. PubMed ID: 14673042 [TBL] [Abstract][Full Text] [Related]
11. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer. Rufián S; Muñoz-Casares FC; Briceño J; Díaz CJ; Rubio MJ; Ortega R; Ciria R; Morillo M; Aranda E; Muntané J; Pera C J Surg Oncol; 2006 Sep; 94(4):316-24. PubMed ID: 16917864 [TBL] [Abstract][Full Text] [Related]
12. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome. Brouquet A; Goéré D; Lefèvre JH; Bonnet S; Dumont F; Raynard B; Elias D Ann Surg Oncol; 2009 Oct; 16(10):2744-51. PubMed ID: 19626375 [TBL] [Abstract][Full Text] [Related]
13. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049 [TBL] [Abstract][Full Text] [Related]
15. Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy. Hosch WP; Rudi J; Stremmel W Z Gastroenterol; 1999 Jul; 37(7):615-22. PubMed ID: 10458011 [TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery plus intraperitoneal hyperthermic perfusion is an effective treatment for metastasized malignant mixed mesodermal tumours (MMMT)--report of six cases. Müller H; Nakchbandi V Eur J Surg Oncol; 2004 Jun; 30(5):573-7. PubMed ID: 15135489 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach. Sugarbaker PH Expert Opin Pharmacother; 2009 Aug; 10(12):1965-77. PubMed ID: 19563273 [TBL] [Abstract][Full Text] [Related]
18. [Intraoperative (hyperthermic) intraperitoneal chemotherapy--considerations and aspects of safe intra- and postoperative treatment with cytostatic drugs]. Jähne J; Piso P; Schmoll E; Haulitschek-Hauss R; Sterzenbach H; Paul H; Pichlmayr R Langenbecks Arch Chir; 1997; 382(1):8-14. PubMed ID: 9157234 [TBL] [Abstract][Full Text] [Related]
19. [The techniques of peritonectomy and hyperthermic intraperitoneal chemotherapy]. Lang SA; Glockzin G; Dahlke MH; Popp FC; Agha A; Schlitt HJ; Piso P Zentralbl Chir; 2009 Sep; 134(5):443-9. PubMed ID: 19492282 [TBL] [Abstract][Full Text] [Related]
20. The integrated treatment of peritoneal carcinomatosis. A preliminary experience. Cavaliere F; Di Filippo F; Cosimelli M; Aloe L; Arcuri E; Anzà M; Callopoli A; Di Lauro L; Morace E; Botti C; Natoli S; Tedesco M; Giunta S; Cavaliere R J Exp Clin Cancer Res; 1999 Jun; 18(2):151-8. PubMed ID: 10464701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]